The Journal of Neuroscience, December 15, 1999, 19(24):11017-11026
Role of Adenosine A2 Receptors in Brain Stimulation Reward under
Baseline Conditions and during Cocaine Withdrawal in Rats
Brian A.
Baldo,
George F.
Koob, and
Athina
Markou
Division of Psychopharmacology, Department of Neuropharmacology,
The Scripps Research Institute, La Jolla, California 92037, and Program
in Neurosciences, Department of Neuroscience, University of California,
San Diego School of Medicine, La Jolla, California 92093
The present experiments tested the hypothesis that adenosine A2
receptors are involved in central reward function. Adenosine receptor
agonists or antagonists were administered to animals that
had been trained to self-stimulate in a rate-free brain stimulation reward (BSR) task that provides current thresholds as a measure of
reward. The adenosine A2A receptor-selective agonists
2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido adenosine hydrochloride (CGS 21680) (0.1-1.0 mg/kg) and
2-[(2-aminoethylamino)carbonylethyl phenylethylamino]-5'-N-ethylcarboxamido adenosine
(APEC) (0.003-0.03 mg/kg) elevated reward thresholds without
increasing response latencies, a measure of performance. Specifically,
CGS 21680 had no effect on response latency, whereas APEC shortened
latencies. Bilateral infusion of CGS 21680 (3, 10, and 30 ng/side),
directly into the nucleus accumbens, elevated thresholds but shortened latencies. The highly selective A2A antagonist
8-(3-chlorostyryl)caffeine (0.01-10.0 mg/kg) and the
A2-preferring antagonist 3,7-dimethyl-1-propargylxanthine (DMPX) (0.3-10.0 mg/kg) did not alter thresholds or latencies, but
DMPX (1.0, 10.0 mg/kg) blocked the threshold-elevating effect of APEC
(0.03 mg/kg). In another study, repeated administration of cocaine
(eight cocaine injections of 15 mg/kg, i.p., administered over 9 hr)
produced elevations in thresholds at 4, 8, and 12 hr after cocaine.
DMPX (3 and 10 mg/kg), administered before both the 8 and 12 hr
post-cocaine self-stimulation tests, reversed the threshold elevation
produced by cocaine withdrawal. These results indicate that stimulating
adenosine A2A receptors diminishes BSR without producing
performance deficits, whereas blocking adenosine receptors reverses the
reward impairment produced by cocaine withdrawal or by an
A2A agonist. These findings indicate that adenosine, via
A2A receptors, may inhibit central reward processes,
particularly during the neuroadaptations associated with chronic
drug-induced neuronal activation.
Key words:
adenosine; adenosine A2A receptor; dopamine; brain stimulation reward; nucleus accumbens; cocaine; withdrawal; DMPX; CGS 21680; APEC; chlorostyryl-caffeine
Copyright © 1999 Society for Neuroscience 0270-6474/99/192411017-10$05.00/0